OmniAb, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OABI research report →
Companywww.omniab.com
OmniAb, Inc. , a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics.
- CEO
- Matthew W. Foehr
- IPO
- 2021
- Employees
- 114
- HQ
- EmeryVille, CA, US
Price Chart
Valuation
- Market Cap
- $307.25M
- P/E
- -6.10
- P/S
- 10.63
- P/B
- 1.26
- EV/EBITDA
- -8.48
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 35.45%
- Op Margin
- -200.35%
- Net Margin
- -187.74%
- ROE
- -20.31%
- ROIC
- -20.39%
Growth & Income
- Revenue
- $18.67M · -29.27%
- Net Income
- $-64,779,000 · -4.43%
- EPS
- $-0.57 · 6.56%
- Op Income
- $-71,518,000
- FCF YoY
- 10.88%
Performance & Tape
- 52W High
- $2.61
- 52W Low
- $1.22
- 50D MA
- $1.65
- 200D MA
- $1.74
- Beta
- 0.62
- Avg Volume
- 589.84K
Get TickerSpark's AI analysis on OABI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 21, 26 | Gotwals Philip J | other | 13,333 |
| Apr 21, 26 | Gotwals Philip J | other | 13,333 |
| Apr 21, 26 | Crouse Steven C. | other | 13,333 |
| Apr 21, 26 | Crouse Steven C. | other | 13,333 |
| Apr 7, 26 | FOEHR MATTHEW W | other | 36,459 |
| Apr 7, 26 | FOEHR MATTHEW W | sell | 19,244 |
| Apr 7, 26 | FOEHR MATTHEW W | other | 36,459 |
| Apr 7, 26 | GUSTAFSON KURT A | other | 13,542 |
| Apr 7, 26 | GUSTAFSON KURT A | sell | 6,913 |
| Apr 7, 26 | GUSTAFSON KURT A | other | 13,542 |
Our OABI Coverage
We haven't published any research on OABI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate OABI Report →